SCHEMBL6207151

SCHEMBL6207151

CC(c1ccncc1NS(=O)(=O)c1ccccc1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CCR9 P51686 4/20 0.44
LMNA P02545 1/20 0.41
SLC40A1 Q9NP59 3/20 0.39
FFAR4 Q5NUL3 1/20 0.36
ADRB2 P07550 2/20 0.34
ADRB1 P08588 2/20 0.34
ADRB3 P13945 2/20 0.34
PTGES2 Q9H7Z7 1/20 0.34
LIPE Q05469 4/20 0.34
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177185 0.89 LMNA (0.41) CCR9LMNALIPE
SCHEMBL6173841 0.89 LIPE (0.41) CCR9LMNALIPE
SCHEMBL6175499 0.87 LMNA (0.37) CCR9LMNALIPE
SCHEMBL6176639 0.87 OXTR (0.36) CCR9LMNA
SCHEMBL6173101 0.87 LMNA (0.38) CCR9LMNALIPE
SCHEMBL6173186 0.85 LMNA (0.40) CCR9LMNALIPE
SCHEMBL6172197 0.84 LMNA (0.40) CCR9LMNALIPE
SCHEMBL6176663 0.83 LMNA (0.39) LMNA
SCHEMBL6175831 0.83 NPC1 (0.46) LMNA
SCHEMBL6173298 0.83 LMNA (0.39) CCR9LMNALIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed